Precigen (PGEN) Divestments (2018 - 2022)
Precigen (PGEN) posted quarterly Divestments of $936000.0 for Q4 2022, down 98.54% quarter-over-quarter from $64.2 million in Q1 2020.
Powered by 
Analysis
Precigen (PGEN) Divestments (2018 - 2022) Analysis & Trends
Precigen (PGEN) has reported Divestments for 4 consecutive years, with $936000.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Divestments changed N/A year-over-year to $936000.0; the TTM figure through Dec 2023 stood at $936000.0 (changed 0.0% YoY), while the FY2022 annual figure was $162.3 million, changed N/A from the prior year.
- Divestments fell to $936000.0 in Q4 2022 per PGEN's latest filing, from $64.2 million in the prior quarter.
- Across five years, Divestments topped out at $64.2 million in Q1 2020 and bottomed at -$125000.0 in Q4 2019.
- Historically, Divestments has averaged $13.6 million across 4 years, with a median of $936000.0 in 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 936,000.00 |
| Mar 31, 2020 | 64.24 Mn |
| Sep 30, 2019 | 125,000.00 |
| Mar 31, 2018 | 2.60 Mn |